These include: Prediabetes High blood pressure High cholesterol Atherosclerotic cardiovascular disease Osteoarthritis Fatty liver disease Polycystic ovary syndrome (PCOS) Obstructive sleep apnea Inflammatory states Research is ongoing to better understand the potential benefits of GLP-1 medications for heart disease, kidney disease and inflammation-related conditions
It has also been associated with melanoma, an invasive skin cancer with a high risk of death
Both semaglutide and alcohol place demands on liver function, and combining them increases health risks
However, severe bloating paired with vomiting, intense pain, or inability to eat or drink warrants immediate medical attention
Areas of interest included cardiovascular disease, sleep apnea, and neurodegenerative disorders, with attention given to how ongoing research may further expand the role of these agents across multiple disease states
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways